Aarti Industries Ltd
Aarti Industries Ltd, the flagship company of the Aarti group, manufacturing organic and inorganic chemicals at its major facilities in Vapi, Jhagadia, Dahej and Kutch, in Gujarat and in Tarapur in Maharashtra. The company has a strong market position in the NCB-based specialty chemicals segment.[1]
- Market Cap ₹ 17,765 Cr.
- Current Price ₹ 489
- High / Low ₹ 552 / 338
- Stock P/E 34.4
- Book Value ₹ 165
- Dividend Yield 0.20 %
- ROCE 6.84 %
- ROE 7.17 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 2.96 times its book value
- Tax rate seems low
- Company has a low return on equity of 7.19% over last 3 years.
- Dividend payout has been low at 9.32% of profits over last 3 years
- Debtor days have increased from 58.4 to 80.8 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,853 | 2,934 | 3,050 | 3,699 | 4,025 | 3,994 | 4,317 | 6,040 | 6,565 | 6,346 | 7,302 | 8,422 | 9,040 | |
| 2,396 | 2,404 | 2,442 | 3,043 | 3,108 | 3,065 | 3,382 | 4,329 | 5,477 | 5,368 | 6,300 | 7,259 | 7,723 | |
| Operating Profit | 456 | 530 | 608 | 657 | 917 | 930 | 935 | 1,711 | 1,088 | 978 | 1,002 | 1,163 | 1,317 |
| OPM % | 16% | 18% | 20% | 18% | 23% | 23% | 22% | 28% | 17% | 15% | 14% | 14% | 15% |
| 5 | 10 | 3 | 2 | 5 | 11 | 2 | 1 | 0 | 7 | 23 | 14 | 13 | |
| Interest | 137 | 116 | 117 | 131 | 179 | 122 | 86 | 102 | 166 | 211 | 275 | 339 | 360 |
| Depreciation | 79 | 93 | 115 | 136 | 151 | 173 | 218 | 244 | 310 | 377 | 433 | 473 | 483 |
| Profit before tax | 246 | 331 | 379 | 392 | 591 | 646 | 632 | 1,366 | 613 | 396 | 316 | 365 | 487 |
| Tax % | 24% | 24% | 19% | 19% | 19% | 19% | 19% | 13% | 11% | -5% | -7% | -16% | |
| 188 | 252 | 307 | 316 | 481 | 523 | 514 | 1,182 | 546 | 417 | 340 | 422 | 524 | |
| EPS in Rs | 5.30 | 7.58 | 9.34 | 9.73 | 13.88 | 15.02 | 14.74 | 32.61 | 15.06 | 11.51 | 9.37 | 11.65 | 14.44 |
| Dividend Payout % | 26% | 28% | 3% | 3% | 20% | 12% | 10% | 11% | 17% | 9% | 11% | 9% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 9% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -4% |
| 3 Years: | -9% |
| TTM: | 111% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -10% |
| 3 Years: | 0% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 44 | 42 | 41 | 41 | 43 | 87 | 87 | 181 | 181 | 181 | 181 | 181 |
| Reserves | 864 | 1,052 | 1,269 | 1,475 | 2,517 | 2,815 | 3,325 | 4,320 | 4,740 | 5,111 | 5,437 | 5,791 |
| 1,201 | 1,275 | 1,545 | 2,047 | 2,366 | 2,073 | 2,851 | 2,581 | 2,907 | 3,622 | 3,846 | 4,965 | |
| 710 | 467 | 485 | 620 | 702 | 1,115 | 1,251 | 748 | 762 | 1,228 | 1,651 | 2,222 | |
| Total Liabilities | 2,819 | 2,836 | 3,341 | 4,182 | 5,628 | 6,089 | 7,514 | 7,830 | 8,590 | 10,143 | 11,115 | 13,159 |
| 936 | 1,170 | 1,567 | 1,844 | 1,979 | 2,302 | 3,511 | 3,635 | 4,824 | 5,605 | 6,330 | 6,355 | |
| CWIP | 188 | 307 | 267 | 431 | 795 | 1,418 | 1,298 | 1,303 | 1,096 | 1,229 | 1,457 | 2,187 |
| Investments | 63 | 56 | 62 | 56 | 33 | 37 | 36 | 3 | 12 | 19 | 90 | 189 |
| 1,632 | 1,304 | 1,446 | 1,850 | 2,820 | 2,333 | 2,669 | 2,889 | 2,658 | 3,289 | 3,239 | 4,428 | |
| Total Assets | 2,819 | 2,836 | 3,341 | 4,182 | 5,628 | 6,089 | 7,514 | 7,830 | 8,590 | 10,143 | 11,115 | 13,159 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 357 | 550 | 411 | 312 | 700 | 1,065 | 844 | 507 | 1,272 | 1,159 | 1,229 | 608 | |
| -323 | -424 | -470 | -574 | -768 | -1,109 | -1,307 | -1,162 | -1,301 | -1,317 | -1,382 | -1,141 | |
| -20 | -128 | 57 | 264 | 839 | -520 | 635 | 417 | 55 | 421 | -74 | 746 | |
| Net Cash Flow | 14 | -2 | -3 | 2 | 771 | -564 | 173 | -239 | 27 | 263 | -227 | 213 |
| Free Cash Flow | 64 | 115 | -61 | -266 | -68 | -49 | -463 | -656 | -19 | -104 | -146 | -513 |
| CFO/OP | 91% | 119% | 82% | 62% | 89% | 131% | 100% | 44% | 125% | 128% | 122% | 52% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 65 | 66 | 69 | 73 | 72 | 69 | 68 | 54 | 51 | 43 | 81 |
| Inventory Days | 124 | 104 | 124 | 132 | 139 | 167 | 186 | 137 | 115 | 121 | 119 | 94 |
| Days Payable | 57 | 66 | 67 | 67 | 53 | 69 | 121 | 53 | 47 | 79 | 105 | 122 |
| Cash Conversion Cycle | 126 | 103 | 123 | 135 | 159 | 169 | 135 | 153 | 122 | 93 | 56 | 52 |
| Working Capital Days | 11 | 7 | -4 | 6 | -14 | -15 | -38 | 23 | -28 | -35 | -43 | -55 |
| ROCE % | 19% | 20% | 19% | 16% | 18% | 15% | 13% | 22% | 10% | 7% | 6% | 7% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Export Share of Revenue % |
|
|||||||||
| Manufacturing Plants count |
||||||||||
| DCB Capacity Utilization % |
||||||||||
| MMA Production Volume kT |
||||||||||
| NCB Capacity Utilization % |
||||||||||
| Energy Application Revenue Share % |
||||||||||
| MMA Capacity Utilization % |
||||||||||
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
- Allotment of Equity Shares under Aarti Industries Limited PSOP 2022
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- AGM passed FY26 results, 20% dividend, and appointed Suyog K. Kotecha as MD from Oct. 1, 2026.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
- Investor Presentation made at 43rd Annual General Meeting
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 43rd AGM held on September 21, 2026; Suyog Kotecha appointed MD from October 1, 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Sep 2026PPT
-
Aug 2026Transcript PPT REC
-
May 2026Transcript PPT
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
Jul 2025PPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT REC
-
Aug 2024PPT
-
Aug 2024PPT
-
Aug 2024PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Aug 2023PPT
-
May 2023Transcript PPT REC
-
Mar 2023PPT
-
Mar 2023PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Sep 2022PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022PPT
-
Nov 2021Transcript PPT
-
Sep 2021PPT
-
Aug 2021Transcript PPT
-
Jun 2021PPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
May 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jul 2019PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018Transcript PPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017Transcript
-
Aug 2017Transcript
-
Jun 2017Transcript PPT
-
Mar 2017Transcript
-
Nov 2016Transcript
-
Aug 2016Transcript
-
Jun 2016Transcript PPT
-
Apr 2016PPT
-
Mar 2016PPT
-
Mar 2016PPT
-
Feb 2016Transcript PPT
-
Jan 2016PPT
Product Portfolio[1]
The company’s key product value chains include Nitro Chloro Benzenes (NCB), Di-Chloro Benzenes (DCB), Phenylenediamines (PDA), Nitro Toluene derivatives, and Sulphuric Acid & downstream products, with a portfolio of over 100 products.